Rhodes Serum Dioxin Study Information Night Wednesday 13 October - - PowerPoint PPT Presentation

rhodes serum dioxin study
SMART_READER_LITE
LIVE PREVIEW

Rhodes Serum Dioxin Study Information Night Wednesday 13 October - - PowerPoint PPT Presentation

Rhodes Serum Dioxin Study Information Night Wednesday 13 October 2004 Rhodes Serum Dioxin Study 1. Background 2. Study logistics 3. Interpretation of study results Background Dioxins organochlorine compounds produced during


slide-1
SLIDE 1

Rhodes Serum Dioxin Study

Information Night Wednesday 13 October 2004

slide-2
SLIDE 2

Rhodes Serum Dioxin Study

  • 1. Background
  • 2. Study logistics
  • 3. Interpretation of study results
slide-3
SLIDE 3

Background

  • Dioxins
  • organochlorine compounds
  • produced during incomplete combustion
  • natural processes eg bushfires
  • chemical processes eg paper bleaching
  • industrial processes eg pesticide

manufacture

slide-4
SLIDE 4

Why are dioxins a problem?

  • Persistent in the environment
  • Accumulate in fat up the food chain
  • Mass release in industrialised

countries in 1930s-60s

  • Toxic
slide-5
SLIDE 5

Dioxin toxicity

  • Promote cancer in animal studies
  • Associated with cancer (esp lung and

blood) in people

  • occupationally exposed for more than 1

year

  • 20 or more years latency
  • Other effects in people occupationally

exposed eg skin conditions

slide-6
SLIDE 6

What levels are toxic?

  • International debate about possible

effects of dioxins at lower levels

  • Little solid evidence to date of effects

in humans at levels most people are exposed to

  • NHMRC established tolerable

monthly intake for Australians in 2002

slide-7
SLIDE 7

International Body Burdens

  • All populations have been exposed to

dioxins

  • 95-99% of exposure

is through diet

  • Fish and meat
  • Eggs and dairy products
slide-8
SLIDE 8

International body burdens

  • Levels are falling internationally since

decreased production 20-30 years ago

  • Older people have higher body

burdens

slide-9
SLIDE 9

Average concentration of TCDD in human blood from general populations

1.52 2.1 2.5 2.9 3.1 3.6 4.1 4.5 5.6 7 1 2 3 4 5 6 7 8

Spain (Madrid), 1993 USA, 1995-1997 Sweden, 1990 Germany, 1994 Japan, 1991-1992 Norway, 1993 Finland, 1989-1990 Russia (St Petersburg), 1988-1989 New Zealand, 1988 USA, 1987-1988 Place and time of measurement

TCDD concentration (ng/kg fat)

slide-10
SLIDE 10
  • Dioxins in Australia
  • National Dioxin Assessment
  • Levels in Australian population lower

than other industrialised countries

  • Website

www.deh.gov.au/industry/chemicals/dio xins/index.html

slide-11
SLIDE 11

Australian serum dioxin levels in National Dioxin Assessment

(South East Urban, TEQ pg/g lipid)

5 10 15 20 25 30 <16 yrs 16-30 yrs 31-45 yrs 46-60 yrs >60 yrs Males Females

slide-12
SLIDE 12

Dioxin levels in perspective

  • Serum levels associated with cancer

and other effects in occupational cohorts

  • Mean 1400-2200 pg/g
  • Serum levels of Australians
  • Mean 10.9 pg/g
slide-13
SLIDE 13

Rhodes Serum Dioxin Study

slide-14
SLIDE 14

Aim

  • To follow blood dioxin levels during

remediation to:

  • Identify an increase requiring review of

remediation control measures or

  • To reconfirm that remediation measures

have been effective

slide-15
SLIDE 15

Why?

  • Dioxins on sites to be remediated
  • Modelling » small levels of dioxin

containing dust

  • Community concern
  • Monitoring on site
  • Extra level of monitoring of residents
slide-16
SLIDE 16

How?

  • 50 mls of blood donated from eligible

people

  • Now
  • at the peak of remediation
  • at the end of remediation
  • Blood from a control group
  • Short questionnaire
slide-17
SLIDE 17

50mls is 5 X 10ml tubes No other tests needed

slide-18
SLIDE 18

How?

  • Dioxin in serum ~ body burden
  • Measurement on pooled blood
slide-19
SLIDE 19
  • Who is eligible to participate?
  • 200 volunteers
  • Men 30 and over
  • Women 45 and over
  • People living on the peninsula who

intend to stay living here for the next 5 years

  • Not previously worked with pesticides or

at the Union Carbide site

slide-20
SLIDE 20
slide-21
SLIDE 21

Why these people?

  • Greatest impact, if any
  • Feasible
  • exclude children
  • Reduce variability
  • eg pregnancy and breastfeeding change

body burdens

slide-22
SLIDE 22

What does participation involve?

  • Registration
  • Completion of Consent Form and

Questionnaire

  • Donation of a 50ml blood sample at

Davies Campbell de Lambert Pathology, 2 Leeds St Rhodes

slide-23
SLIDE 23

What do we need?

  • As many people as possible to

donate blood (at least 40)

  • Precision depends on number of

people who participate

  • Community input and agreement

regarding timing of second and third collections

slide-24
SLIDE 24

Interpretation of results

slide-25
SLIDE 25

Possible results

  • Rhodes- Control: no change
  • Rhodes- Control: decreased
  • Rhodes- Control: increased
  • by how much?
  • is it significant?
slide-26
SLIDE 26

Time 1 Time 2 Time 0

ACTION

Difference  8.5ng Control group Rhodes group Rhodes group Rhodes group Control group Control group Difference  8.5ng YES NO NO YES

slide-27
SLIDE 27

Interpretation

  • Level of detection based upon

Tolerable Monthly Intake

  • Detection of a change does not mean

increased risk of health effect

  • Detection of a change may mean

remediation controls not strict enough

slide-28
SLIDE 28

Summary

  • The Rhodes Serum Dioxin Study

aims to detect if there has been an increase in the community’s exposure to dioxin whilst remediation is being conducted on the Rhodes peninsula

slide-29
SLIDE 29

NSW Health Project Team

  • Dr Michael Staff
  • Dr Vicky Sheppeard
  • Dr Alison Rutherford
  • Dr Bradley Forssman
  • More information at

www.health.nsw.gov.au/rhodes

  • Contact us on 9816 0234
slide-30
SLIDE 30

Clinic times

  • Davies Campbell de Lambert

Pathology, 2 Leeds St Rhodes

  • Thursday 14 October 5pm-830pm
  • Friday 15 October 10am-12pm and 3-

6pm

  • Saturday 16 October 9am-1230pm